Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 2

Status

Completed 6Unknown 1Active not recruiting 1

Sponsor Class

INDUSTRY 250OTHER 6NETWORK 6NIH 3

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1CNS 1

Conditions

Recurrence 1Ototoxicity 1Neuroblastoma 1Neoplasms 1Lymphoma, B-Cell 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Hepatoblastoma 1Graft vs Host Disease 1Burkitt Lymphoma 1

Interventions

sodium thiosulfate 1Vincristine 1Rituximab 1Methotrexate 1Eflornithine 1Drug Therapy 1Doxorubicin 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × OTHER × Has announcements × Clear all
NCT01516580 2026-02-09

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Completed
482 enrolled 1 FDA
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell

NCT01743131 2025-12-11

Abatacept as GVHD Prophylaxis Phase 2

Boston Children's Hospital

Phase 2 Completed
186 enrolled 14 charts 1 FDA

Graft vs Host Disease, Neoplasms

NCT03581786 2025-09-02

The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

Shanghai Junshi Bioscience Co., Ltd.

Phase 3 Completed
289 enrolled 32 charts 1 FDA

Recurrence

NCT02395666 2024-08-06

Preventative Trial of Difluoromethylornithine (DFMO) in High Risk Patients With Neuroblastoma That is in Remission

Milton S. Hershey Medical Center

Phase 2 Completed
140 enrolled 14 charts 1 FDA
CNS

Neuroblastoma

NCT00652132 2018-05-29

SIOPEL6

University of Birmingham

Phase 3 Completed
116 enrolled 1 FDA
Gastrointestinal

Ototoxicity, Liver Neoplasms, Hepatoblastoma

NCT00927498 2013-07-11

A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old

Acute Leukemia French Association

Phase 3 Completed
280 enrolled 1 FDA
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡